Alexander D. Douglas
Oxford, ENG OX37DQ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response.
Journal: Vaccines
Published: April 13, 2026
Progress and prospects for herpesvirus vaccination using gB antigens.
Journal: Frontiers in immunology
Published: March 10, 2026
From Breath to Beatitude: Spinoza in Respiratory Medicine.
Journal: Respirology (Carlton, Vic.)
Published: October 02, 2025
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial.
Journal: The Lancet. Infectious diseases
Published: September 30, 2025
Rabies glycoprotein engineering for improved stability and expression.
Journal: Vaccine
Published: April 28, 2025
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Journal: Nature communications
Published: February 20, 2024
A screen for Plasmodium falciparum sporozoite surface protein binding to human hepatocyte surface receptors identifies novel host-pathogen interactions.
Journal: Malaria journal
Published: December 07, 2023
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Journal: Wellcome open research
Published: November 22, 2023
Accelerated and intensified manufacturing of an adenovirus-vectored vaccine to enable rapid outbreak response.
Journal: Biotechnology and bioengineering
Published: April 20, 2023
Rapid-response manufacturing of adenovirus-vectored vaccines.
Journal: Nature biotechnology
Published: March 08, 2023
Last Updated: 09/26/2026